Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What are 10K annual reports?

10K reports are comprehensive annual reports filed by public companies with the SEC, containing detailed financial statements, business operations, risk factors, and management discussion.

How often are annual reports updated?

Annual reports are typically filed once per year, usually within 60-90 days after the company's fiscal year end. We update our database as soon as new reports become available.

How do I analyze MLAB stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate MLAB investment potential.

What is MLAB stock price today?

Get real-time MLAB stock price, historical data, and price charts on Financhill. Track MLAB performance with our advanced analysis tools.

Is MLAB a good investment?

Evaluate MLAB investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy MLAB stock?

To buy MLAB stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of MLAB?

View detailed market capitalization data and company valuation metrics for MLAB on our comprehensive analysis page.

What is the P/E ratio of MLAB?

Use our fundamental analysis tools to view MLAB P/E ratio and compare valuation metrics with industry peers.

What are MLAB earnings?

View MLAB earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Mesa Laboratories, Inc. 10K Form

Buy

MLAB
Mesa Laboratories, Inc.

Last Price:

$89.93

Seasonality Move:

8.14%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-02-05	10Q	MLAB/Mesa Laboratories, Inc. Quarterly
2023-11-06	10Q	MLAB/Mesa Laboratories, Inc. Quarterly
2023-08-03	10Q	MLAB/Mesa Laboratories, Inc. Quarterly
2023-02-06	10Q	MLAB/Mesa Laboratories, Inc. Quarterly
2022-11-03	10Q	MLAB/Mesa Laboratories, Inc. Quarterly
2022-08-04	10Q	MLAB/Mesa Laboratories, Inc. Quarterly

Receive MLAB News And Ratings

See the #1 stock for the next 7 days that we like better than MLAB

MLAB Financial Statistics

Sales & Book Value

Annual Sales:	$241M
Cash Flow:	$18M
Price / Cash Flow:	13.27
Annual Sales:	$33.79
Price / Book:	2.68

Profitability

EPS (TTM):	0.64560
Net Income (TTM):	$3.7M
Gross Margin:	$132.1M
Return on Equity:	2.19%
Return on Assets:	0.86%

Mesa Laboratories, Inc. Earnings Forecast

Key Mesa Laboratories, Inc. Financial Ratios

The Gross Profit Margin over the past 38 years for MLAB is 54.84%.
The Selling, General & Administrative Expenses for MLAB have been equal to 47.73% of Gross Profit Margin.
The Research & Development expenses have been 8.10% of Revenue.
The Net Earning history of MLAB is -0.82% of Total Revenues.
Per Share Earnings over the last 38 years have been positive in 24 years.

Mesa Laboratories, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	NASDAQ
Industry:	Life Sciences Tools & Services
Sector:	Health Care
Current Symbol:	MLAB
CUSIP:	59064R
Website:	mesalabs.com

Debt

Debt-to-Equity Ratio:	0.91
Current Ratio:	1.94
Quick Ratio:	1.32

Price-to-Earnings

Trailing P/E Ratio:	0
Forward P/E Ratio:	16.81

MLAB Technical Analysis vs Fundamental Analysis

Buy

Mesa Laboratories, Inc. (MLAB) is a Buy

Is Mesa Laboratories, Inc. a Buy or a Sell?

Mesa Laboratories, Inc. stock is rated a Buy

The current Mesa Laboratories, Inc. [MLAB] share price is $90.59. The Score for MLAB is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.